Product: VeriStrat
-
Molecular and Translational Biology of the Blood-Based VeriStrat Proteomic Test Used in Cancer Immunotherapy Treatment Guidance
-
Real World Efficacy Of First-Line Immunotherapy With Or Without Chemotherapy In Advanced NSCLC Stratified By Serum Proteomics
-
Real-world demographics, baseline characteristics, healthcare resource utilization and costs amongst non-small cell lung cancer (NSCLC) patients tested with a Host Immune Classifier (HIC)
-
Host Immune Profiling in First-line Immunotherapy Treated Advanced Stage Non-Small Cell Lung Cancer: Results from the INSIGHT Registry Study
-
The role of serum proteomic signature in predicting survival in PD-L1 low non-small cell lung cancer receiving immune checkpoint inhibitor (ICI)
-
Explaining multivariate molecular diagnostic tests via Shapley values
-
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer
-
The role of serum proteomic signature in predicting survival by PD-L1 status in patients with non-small cell lung cancer receiving immunotherapy
-
Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test
-
Longitudinal blood-based proteomic testing in advanced non-small cell lung cancer